{"id":23213,"date":"2026-11-20T13:49:22","date_gmt":"2026-11-20T11:49:22","guid":{"rendered":"https:\/\/farmacija-mic.lv\/?p=23213"},"modified":"2026-11-20T13:49:23","modified_gmt":"2026-11-20T11:49:23","slug":"psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/","title":{"rendered":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Psori\u0101ze ir hroniska, recidiv\u0113jo\u0161a slim\u012bba, kuras rad\u012bt\u0101s izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 veicina strauju epidermas atjauno\u0161anos. Psori\u0101zes pato\u0123en\u0113ze ietver \u0123en\u0113tisku predispoz\u012bciju un vides vai dz\u012bvesveida faktoru mijiedarb\u012bbu. Psori\u0101ze ir saist\u012bta ar liel\u0101ku blakusslim\u012bbu skaitu un iev\u0113rojamu psiholo\u0123isko slogu, kas var pasliktin\u0101t dz\u012bves kvalit\u0101ti. Slimniekiem bie\u017ei ir stress, trauksme un depresija. Nieze, s\u0101pes, funkcion\u0101li ierobe\u017eojumi un soci\u0101l\u0101 stigma pastiprina psiholo\u0123isko stresu. \u0100rst\u0113\u0161anas m\u0113r\u0137is ir mazin\u0101t iekaisumu, kontrol\u0113t simptomus un nov\u0113rst slim\u012bbas progres\u0113\u0161anu, izmantojot lok\u0101lus un sist\u0113miskus l\u012bdzek\u013cus, fototerapiju, biolo\u0123iskas z\u0101les un, ja nepiecie\u0161ams, psiholo\u0123iskas metodes. Farmaceita loma \u0161aj\u0101 proces\u0101 ir konsult\u0113t pacientu par \u0101rst\u0113\u0161anu, uzraudz\u012bt terapeitisko atbildreakciju, lai optimiz\u0113tu ilgtermi\u0146a kl\u012bniskos rezult\u0101tus.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Psori\u0101zes gad\u012bjum\u0101 izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 izraisa keratinoc\u012btu hiperprolifer\u0101ciju, radot iekaisumu gan epiderm\u0101, gan derm\u0101. Psori\u0101zi uzskata ne tikai par dermatolo\u0123isku slim\u012bbu, bet ar\u012b par hronisku iekaisumu, kas skar da\u017e\u0101das organisma sist\u0113mas&nbsp;(1).<br>Psori\u0101zes slimniekiem ir liel\u0101ka citu slim\u012bbu sastopam\u012bba \u2013 t\u0101s ir sirds un asinsvadu slim\u012bbas, 2. tipa cukura diab\u0113ts, metabolais sindroms, aptauko\u0161an\u0101s, psori\u0101tiskais artr\u012bts, nealkohola taukaino aknu slim\u012bba un iekais\u012bga zarnu slim\u012bba. \u0160\u012bs slim\u012bbas kop\u0101 ar psori\u0101zi palielina psiholo\u0123isko slogu, ar\u012b depresijas un trauksmes l\u012bmeni (1, 2).<br>ASV Nacion\u0101lais psori\u0101zes fonds (NPF) l\u0113\u0161, ka psori\u0101ze skar 2\u20133% pasaules iedz\u012bvot\u0101ju jeb 125 miljonus cilv\u0113ku, no kuriem vair\u0101k nek\u0101 asto\u0146i miljoni ir ASV. Psori\u0101tiskais artr\u012bts att\u012bst\u0101s aptuveni 30% psori\u0101zes pacientu (3).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pato\u0123en\u0113ze un riska faktori<\/strong><br>Psori\u0101zei ir sare\u017e\u0123\u012bta, daudzpus\u012bga pato\u0123en\u0113ze, kur\u0101 mijiedarbojas \u0123en\u0113tisk\u0101 predispoz\u012bcija, iedzimt\u0101s un adapt\u012bv\u0101s imunit\u0101tes trauc\u0113jumi, k\u0101 ar\u012b da\u017e\u0101di vides un dz\u012bvesveida faktori (1, 2). Psori\u0101zes gad\u012bjum\u0101 im\u016bnsist\u0113mas izrais\u012bts iekaisums sa\u012bsina norm\u0101lu epidermas atjauno\u0161an\u0101s ciklu no 28 dien\u0101m l\u012bdz aptuveni 3-5 dien\u0101m, izraisot trauc\u0113tu keratinoc\u012btu nobrie\u0161anu un to strauju atjauno\u0161anos (1). Ir labi pier\u0101d\u012bta \u0123en\u0113tisk\u0101 predispoz\u012bcija \u2013 tiek l\u0113sts, ka aptuveni 40% psori\u0101zes pacientu ir k\u0101ds radinieks ar psori\u0101zi un\/vai psori\u0101tisko artr\u012btu (1, 4).<br>Slim\u012bbas progres\u0113\u0161anu nosaka im\u016bnregul\u0101cijas trauc\u0113jumi (1). Galvenie citok\u012bni, kas veicina keratinoc\u012btu prolifer\u0101ciju un iekaisumu, ir Th17 \u0161\u016bnu produc\u0113tie IL-17 un IL-22\u00a0(1).<br>Psori\u0101zi var provoc\u0113t vai saasin\u0101t da\u017e\u0101di vesel\u012bbas trauc\u0113jumi, dz\u012bvesveida faktori un vides ietekme (1, 2, 5).<br>Pie labi zin\u0101miem provoc\u0113jo\u0161iem faktoriem pieder \u0101das traumas (Kebnera fenomens), saules apdegumi, v\u012brusinfekcijas (piem\u0113ram, HIV), bakteri\u0101las infekcijas (\u012bpa\u0161i b\u0113ta hemol\u012btiskie streptokoki pilienveida psori\u0101zes gad\u012bjum\u0101) un daudzi medikamenti (piem\u0113ram, b\u0113ta blokatori, hloroh\u012bns, litijs, AKE inhibitori, indometac\u012bns, terbinaf\u012bns, interferons-alfa, TNF inhibitori, im\u016bnsist\u0113mas kontrolpunktu inhibitori) (2, 5).<br>Papildu riska faktori un provoc\u0113jo\u0161ie faktori ir p\u0101rm\u0113r\u012bga alkohola lieto\u0161ana, sm\u0113\u0137\u0113\u0161ana, aptauko\u0161an\u0101s un sist\u0113misko glikokortiko\u012bdu lieto\u0161anas p\u0101rtrauk\u0161ana, \u012bpa\u0161i eritrodermiskas vai \u0123eneraliz\u0113tas pustulozas psori\u0101zes gad\u012bjum\u0101. Psiholo\u0123iskais stress ir saist\u012bts ar psori\u0101zi, ta\u010du tas nav viennoz\u012bm\u012bgi pier\u0101d\u012bts k\u0101 tie\u0161s riska faktors (2,5).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Slim\u012bbas formas un kl\u012bnisk\u0101 aina<\/strong><br>Psori\u0101zei ir vair\u0101kas at\u0161\u0137ir\u012bgas kl\u012bniskas formas (sk. tabulu), kuru gad\u012bjum\u0101 ir specifiska boj\u0101jumu morfolo\u0123ija, izplat\u012bbas veids, k\u0101 ar\u012b at\u0161\u0137ir\u012bga smaguma pak\u0101pe, bie\u017eums un reakcija uz \u0101rst\u0113\u0161anu (1, 2, 5\u20139). T\u0101 k\u0101 psori\u0101ze ir hroniska un recidiv\u0113jo\u0161a slim\u012bba, simptomi pacienta dz\u012bves laik\u0101 var gan izzust, gan atkal par\u0101d\u012bties (1, 2). Kl\u012bnisk\u0101 aina atkar\u012bb\u0101 no psori\u0101zes veida at\u0161\u0137iras p\u0113c skartaj\u0101m \u0137erme\u0146a zon\u0101m, smaguma pak\u0101pes un paasin\u0101jumu bie\u017euma. Slim\u012bbas gaita bie\u017ei vien ir neparedzama, jo boj\u0101jumi var rasties jebkur\u0101 \u0101das apvid\u016b.<br>Psori\u0101zi galvenok\u0101rt diagnostic\u0113, veicot \u0101das un nagu fizisku izmekl\u0113\u0161anu, lai nov\u0113rt\u0113tu boj\u0101juma morfolo\u0123iju un izplat\u012bbu. \u0100rsts ieg\u016bst detaliz\u0113tu slim\u012bbas v\u0113sturi, lai noteiktu iesp\u0113jamos riska faktorus un izrais\u012bt\u0101jus. Ja izskats ir netipisks vai p\u0101rkl\u0101jas ar cit\u0101m dermatoz\u0113m, diagnozes apstiprin\u0101\u0161anai var veikt \u0101das biopsiju un noteikt papildu p\u0101rbaudes, lai izsl\u0113gtu citus c\u0113lo\u0146us.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tabula. <\/strong>Psori\u0101zes veidi (3, 5\u20139)<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-regular\"><table class=\"has-primary-ink-color has-text-color has-link-color has-fixed-layout\"><tbody><tr><td><strong>Veids <\/strong><\/td><td><strong>Galven\u0101s kl\u012bnisk\u0101s paz\u012bmes<\/strong><\/td><td><strong> Rakstur\u012bg\u0101 lok\u0101cija<\/strong><\/td><td><strong> Bie\u017eums, piez\u012bmes<\/strong><\/td><\/tr><tr><td>Per\u0113k\u013cain\u0101 jeb pl\u0101ksn\u012b\u0161u psori\u0101ze (psoriasis vulgaris) <\/td><td>Skaidri norobe\u017eoti, apa\u013ci vai plakani eritematozi per\u0113k\u013ci ar s\u0101rtu pamatni un sudrabaini balt\u0101m zv\u012b\u0146\u0101m. Nieze (no vieglas l\u012bdz stiprai).<\/td><td> Elko\u0146i, ce\u013cgali, galvas \u0101da, muguras lejasda\u013ca. <\/td><td>80\u201390% psori\u0101zes gad\u012bjumu.<\/td><\/tr><tr><td>Pilienveida psori\u0101ze (psoriasis guttata) <\/td><td>P\u0113k\u0161\u0146s s\u0101kums, 1\u201310 mm apa\u013cas, sarkanas vai bezkr\u0101sainas iekais\u012bgas papulas ar minim\u0101lu zv\u012b\u0146o\u0161anos. <\/td><td>Rokas, k\u0101jas, rumpis vai jebkura \u0137erme\u0146a vieta. <\/td><td>~8% gad\u012bjumu; bie\u017ei provoc\u0113 streptokoku infekcija.<\/td><\/tr><tr><td>Pustuloz\u0101 psori\u0101ze <\/td><td>\u0122eneraliz\u0113ta forma \u2013 p\u0113k\u0161\u0146s s\u0101kums, pla\u0161i izplat\u012bti sterili pustulozi izsitumi uz eritematozas \u0101das, ko pavada drudzis, nogurums un visp\u0101r\u0113js nesp\u0113ks.<br>Plaukstu un p\u0113du forma \u2013 sterili pustulozi izsitumi uz plaukst\u0101m un p\u0113d\u0101m ar erit\u0113mu, zv\u012b\u0146o\u0161anos un hiperkeratozi.<br>Alopo nep\u0101rtrauktais akrodermat\u012bts (acrodermatitis continua of Hallopeau): recidiv\u0113jo\u0161i pustulozi izsitumi uz pirkstu galiem un ap nagiem ar s\u0101p\u012bgu nagu distrofiju un iesp\u0113jamu kaulaudu zudumu. <\/td><td>Lok\u0101li: plaustas un p\u0113das. \u0122eneraliz\u0113ti: var skart liel\u0101ko da\u013cu \u0137erme\u0146a.<\/td><td> ~3% gad\u012bjumu. \u0122eneraliz\u0113tas formas gad\u012bjum\u0101 sist\u0113misku simptomu d\u0113\u013c var b\u016bt nepiecie\u0161ama neatliekama medic\u012bnisk\u0101 pal\u012bdz\u012bba.<\/td><\/tr><tr><td>Eritrodermisk\u0101 psori\u0101ze <\/td><td>Izteikta, pla\u0161a erit\u0113ma un deskvam\u0101cija, kas skar vair\u0101k nek\u0101 75% \u0137erme\u0146a virsmas. <\/td><td>Gandr\u012bz viss \u0137ermenis.<\/td><td>Reti sastopama (~2%). Var saasin\u0101ties cita apak\u0161tipa ietekm\u0113, provoc\u0113t var infekcija, p\u0113k\u0161\u0146a sist\u0113misk\u0101s terapijas p\u0101rtrauk\u0161ana vai stress. Var rad\u012bt \u0161\u0137idruma un elektrol\u012btu l\u012bdzsvara trauc\u0113jumus, termoregul\u0101cijas trauc\u0113jumus un paaugstin\u0101tu infekcijas risku.<\/td><\/tr><tr><td>Invers\u0101 jeb atgriezenisk\u0101 psori\u0101ze <\/td><td>Boj\u0101jumi ir violeti, br\u016bni vai tum\u0161\u0101ki par p\u0101r\u0113jo \u0101das kroku. <\/td><td>\u0100das krokas \u2013 padus\u0113s, cirk\u0161\u0146os, zem kr\u016bt\u012bm, starp s\u0113\u017eamvietas daiv\u0101m. <\/td><td>21\u201330% gad\u012bjumu.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u0100rst\u0113\u0161anas ieteikumi<\/strong><br>T\u0101 k\u0101 psori\u0101ze nav piln\u012bgi iz\u0101rst\u0113jama, pamatm\u0113r\u0137is ir pan\u0101kt stabilu slim\u012bbas kontroli, mazin\u0101t iekaisumu un kav\u0113t progres\u0113\u0161anu (10). Agr\u012bna slim\u012bbas atpaz\u012b\u0161ana, t\u016bl\u012bt\u0113ja iejauk\u0161an\u0101s un laba l\u012bdzest\u012bba var b\u016btiski pal\u0113nin\u0101t slim\u012bbas progres\u0113\u0161anu, k\u0101 ar\u012b uzlabot kl\u012bniskos rezult\u0101tus un ar vesel\u012bbu saist\u012bto dz\u012bves kvalit\u0101ti (3,4,8). \u0100rst\u0113\u0161anas izv\u0113li nosaka simptomi, blakusslim\u012bbas, pacienta v\u0113lmes, iepriek\u0161\u0113j\u0101 reakcija uz \u0101rst\u0113\u0161anu un terapijas pieejam\u012bba. \u0100rst\u0113\u0161ana j\u0101piel\u0101go, \u0146emot v\u0113r\u0101 slim\u012bbas smaguma pak\u0101pi, skarto zonu apjomu un lokaliz\u0101ciju, psori\u0101tisk\u0101 artr\u012bta kl\u0101tb\u016btni, k\u0101 ar\u012b pl\u0101ksn\u012b\u0161u vai zv\u012b\u0146u biezumu, j\u0101v\u0113rt\u0113 pacienta visp\u0101r\u0113jais vesel\u012bbas st\u0101voklis, lietot\u0101s z\u0101les un aler\u0123ija anamn\u0113z\u0113 (5).<br>Psori\u0101zes \u0101rst\u0113\u0161ana var b\u016bt sare\u017e\u0123\u012bta, jo individu\u0101l\u0101 atbildreakcija laika gait\u0101 main\u0101s, un \u0101rstam bie\u017ei vien ir terapija j\u0101maina vai j\u0101kombin\u0113 (5).<br>P\u0113rn publiskota p\u0113t\u012bjuma ENCOMPASS rezult\u0101ti liecina, ka b\u016btiska ir ar\u012b pa\u0161a pacienta ba\u017eu, v\u0113lmju un \u0101rst\u0113\u0161anas m\u0113r\u0137u iek\u013cau\u0161ana \u0101rst\u0113\u0161anas proces\u0101, pie\u0146emot kop\u012bgus l\u0113mumus (11). \u0160\u0101da pieeja nodro\u0161ina, ka v\u0113r\u0101 tiek \u0146emti ne tikai kl\u012bniskie slim\u012bbas faktori, bet ar\u012b t\u0101s ietekme uz ikdienas funkcij\u0101m, labsaj\u016btu un gar\u012bgo vesel\u012bbu (11). Turkl\u0101t pacienti bie\u017ei vien k\u0101 \u0101rst\u0113\u0161anas priorit\u0101ti izvirza t\u012bru \u0101du, niezes mazin\u0101\u0161anu un simptomu kontroli ilgtermi\u0146\u0101, savuk\u0101rt \u0101rsti uzsver \u0101rst\u0113\u0161anas efektivit\u0101ti, iesp\u0113jam\u0101s blaknes un dro\u0161\u012bbu ilgtermi\u0146\u0101 (12).<br>Pacienti un \u0101rsti p\u0101rliecino\u0161i deva priek\u0161roku iek\u0161\u0137\u012bgi lietojam\u0101m z\u0101l\u0113m. Vair\u0101k nek\u0101 90% pacientu, kuri lietoja injic\u0113jamas z\u0101les, apgalvoja, ka p\u0101rietu uz peror\u0101l\u0101m z\u0101l\u0113m, ja t\u0101s pied\u0101v\u0101tu l\u012bdz\u012bgu dro\u0161\u012bbu un efektivit\u0101ti, kas nor\u0101da uz neapmierin\u0101t\u0101m vajadz\u012bb\u0101m psori\u0101zes apr\u016bp\u0113 (12).<br>\u0100rst\u0113\u0161anas pl\u0101ns var ietvert vienu vai vair\u0101kas terapijas metodes, k\u0101 ar\u012b \u0101du aizsarg\u0101jo\u0161us pa\u0161apr\u016bpes pa\u0146\u0113mienus, kas pal\u012bdz mazin\u0101t vai nov\u0113rst slim\u012bbas paasin\u0101jumus (5, 13). Viegl\u0101kas slim\u012bbas formas gad\u012bjum\u0101 pacientiem pietiek ar lok\u0101lu terapiju, savuk\u0101rt vid\u0113ji smagai un smagai psori\u0101zei b\u016bs nepiecie\u0161ama fototerapija vai sist\u0113miska \u0101rst\u0113\u0161ana, lai efekt\u012bvi kontrol\u0113tu sist\u0113misko im\u016bnpatog\u0113no procesu (2).<br>Amerikas Dermatolo\u0123ijas akad\u0113mijas (AAD) un Nacion\u0101l\u0101 psori\u0101zes fonda (NPF) vadl\u012bnijas biolo\u0123iskos l\u012bdzek\u013cus iesaka psori\u0101zes \u0101rst\u0113\u0161anai atbilsto\u0161os gad\u012bjumos (2, 5, 13\u201315).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><br><strong>Psori\u0101zes farmakoterapija (2, 5, 13-15)<br>Lok\u0101lie l\u012bdzek\u013ci<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Lok\u0101lie kortikostero\u012bdi tiek ieteikti pirm\u0101 izv\u0113l\u0113 per\u0113k\u013cain\u0101s psori\u0101zes terapijai rajonos, kas neskar \u0101das krokas.<\/li>\n\n\n\n<li>L\u012bdzek\u013ci, kas \u013cauj samazin\u0101t kortikostero\u012bdu devu (D vitam\u012bna analogs kalcipotriols, kalcineir\u012bna inhibitori \u2013 takrolims, pimekrolims), tiek lietoti monoterapij\u0101 vai kop\u0101 ar kortikostero\u012bdiem, lai mazin\u0101tu kortikostero\u012bdu blaknes. Ilgtermi\u0146a \u0101rst\u0113\u0161an\u0101 svar\u012bgi lietot p\u0101rmai\u0146us ar kortikostero\u012bdiem.<\/li>\n\n\n\n<li>Lok\u0101los l\u012bdzek\u013cus, piem\u0113ram, salicilsk\u0101bi \u0101das att\u012br\u012b\u0161anai no zv\u012b\u0146\u0101m, m\u012bkstino\u0161os l\u012bdzek\u013cus (emolientus), antral\u012bnu un akme\u0146og\u013cu darvu, var lietot monoterapij\u0101 vai kop\u0101 ar lok\u0101liem kortikostero\u012bdiem.<\/li>\n\n\n\n<li>Lok\u0101lo l\u012bdzek\u013cu lieto\u0161ana kop\u0101 ar biolo\u0123isko vai sist\u0113misko terapiju var uzlabot visp\u0101r\u0113jo \u0101rst\u0113\u0161anas efektivi\u00adt\u0101ti.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fototerapija<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ieteicamas da\u017e\u0101das fototerapijas metodes, tostarp \u0161aura un pla\u0161a spektra UVB un m\u0113r\u0137\u0113ts UVB (eksim\u0113rl\u0101zers, eksim\u0113ra gaisma, m\u0113r\u0137tiec\u012bga terapija) starojums. Citas metodes ietver PUVA (psoral\u0113ns plus UVA starojums), fotodinamisko terapiju, Grenca starojumu, gaismas terapiju, G\u0113kermana terapiju un puls\u0113jo\u0161u kr\u0101su l\u0101zeru.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Nebiolo\u0123isk\u0101s terapijas<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ieteicamie l\u012bdzek\u013ci ir metotreks\u0101ts un apremilasts vid\u0113ji smagas vai smagas psori\u0101zes gad\u012bjum\u0101; ciklospor\u012bns smagas, pret \u0101rst\u0113\u0161anu rezistentas, eritrodermiskas, \u0123eneraliz\u0113tas pustulozas vai palmoplant\u0101ras slim\u012bbas gad\u012bjum\u0101, k\u0101 ar\u012b acitret\u012bns (lietots atsevi\u0161\u0137i vai kombin\u0101cij\u0101 ar PUVA\/UVB).<\/li>\n\n\n\n<li>Deukravacitinibs ir apstiprin\u0101ts vid\u0113ji smagas vai smagas per\u0113k\u013cain\u0101s psori\u0101zes un akt\u012bva psori\u0101tisk\u0101 artr\u012bta \u0101rst\u0113\u0161anai pieaugu\u0161ajiem.<\/li>\n\n\n\n<li>Tofacitinibu un leflunom\u012bdu lieto psori\u0101tisk\u0101 artr\u012bta gadijum\u0101.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Biolo\u0123iskie l\u012bdzek\u013ci<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>TNF inhibitori: vid\u0113ji smagas vai smagas per\u0113k\u013cain\u0101s psori\u0101zes gad\u012bjum\u0101 injic\u0113 etanerceptu, infliksimabu, adalimumabu, certolizumabu, bet tikai psori\u0101tisk\u0101 artr\u012bta gad\u012bjum\u0101 golimumabu.<\/li>\n\n\n\n<li>IL-12\/23 inhibitoru ustekinumabu lieto vid\u0113ji smagas vai smagas per\u0113k\u013cain\u0101s psori\u0101zes un psori\u0101tisk\u0101 artr\u012bta gad\u012bjum\u0101.<\/li>\n\n\n\n<li>IL-17 inhibitori: sekukinumabs, iksekizumabs, brodalumabs, bimekizumabs lietojami pret vid\u0113ji smagu vai smagu per\u0113k\u013caino psori\u0101zi un psori\u0101tisko artr\u012btu (atkar\u012bb\u0101 no konkr\u0113t\u0101 l\u012bdzek\u013ca).<\/li>\n\n\n\n<li>IL-23 inhibitori: guselkumabs, tildrakizumabs, risankizumabs lietojami pret vid\u0113ji smagu vai smagu per\u0113k\u013caino psori\u0101zi un psori\u0101tisko artr\u012btu (atkar\u012bb\u0101 no konkr\u0113t\u0101 l\u012bdzek\u013ca).<\/li>\n\n\n\n<li>IL-36 sign\u0101lce\u013ca inhibitors spesolimabs paredz\u0113ts \u0123eneraliz\u0113tas pustulozas psori\u0101zes paasin\u0101jumu gad\u012bjum\u0101.<\/li>\n\n\n\n<li>T-\u0161\u016bnu inhibitors abatacepts lietojams tikai akt\u012bva psori\u0101tisk\u0101 artr\u012bta gad\u012bjum\u0101.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">2025. gada decembr\u012b NPF public\u0113ja ofici\u0101lu zi\u0146ojumu, preciz\u0113jot psori\u0101zes krit\u0113rijus un defin\u0113jot t\u0101s smaguma pak\u0101pes (23).<br>Vid\u0113ji smaga vai smaga psori\u0101ze netiek defin\u0113ta tikai p\u0113c t\u0101, vai slim\u012bba skar 10% \u0137erme\u0146a virsmas laukuma. Turkl\u0101t par vid\u0113ji smagu vai smagu j\u0101uzskata ar\u012b t\u0101da psori\u0101ze, kuru neizdodas pietiekami kontrol\u0113t ar lok\u0101lu terapiju, t\u0101pat ar\u012b gad\u012bjumi, kad skartas \u012bpa\u0161i noz\u012bm\u012bgas \u0137erme\u0146a zonas, piem\u0113ram, galvas matain\u0101 da\u013ca, seja, p\u0113das un plaukstas. \u0160\u0101di pacienti atbilst progres\u012bvu terapijas meto\u017eu krit\u0113rijiem, lai sa\u0146emtu fototerapiju un m\u016bsdien\u012bgu sist\u0113misku \u0101rst\u0113\u0161anu. Efekt\u012bv\u0101m un dro\u0161\u0101m metod\u0113m atbilst ar\u012b biolo\u0123iskie l\u012bdzek\u013ci un peror\u0101las z\u0101les, kas sp\u0113j sist\u0113misk\u0101 l\u012bmen\u012b mazin\u0101t iekaisumu (16).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/dati.zva.gov.lv\/zalu-registrs\/info\/11-0504\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"690\" src=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/09\/noofen-1024x690.jpg\" alt=\"\" class=\"wp-image-23516\" srcset=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/09\/noofen-1024x690.jpg 1024w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/09\/noofen-300x202.jpg 300w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/09\/noofen-1400x943.jpg 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ar vesel\u012bbu saist\u012bt\u0101 dz\u012bves kvalit\u0101te un gar\u012bg\u0101 vesel\u012bba<\/strong><br>Psori\u0101zes ietekme p\u0101rsniedz dermatolo\u0123isko simptomu robe\u017eas un psiholo\u0123iski gr\u016bti panesama var b\u016bt, piem\u0113ram, nieze (\u012bpa\u0161i nakts laik\u0101), s\u0101pes, miega trauc\u0113jumi, koncentr\u0113\u0161an\u0101s gr\u016bt\u012bbas. Bie\u017ei sastopam\u0101s blakusslim\u012bbas, piem\u0113ram, psori\u0101tiskais artr\u012bts un depresija, pastiprina \u0161\u012bs probl\u0113mas (12).<br>Depresija un trauksme ir cie\u0161i saist\u012btas ar psori\u0101zi, skarot attiec\u012bgi l\u012bdz pat 33,3% un 25% pacientu (17). Ja t\u0101s netiek laikus atpaz\u012btas un \u0101rst\u0113tas, depresija un trauksme var pasliktin\u0101t psori\u0101zes slimnieka st\u0101vokli. Depresija \u012bpa\u0161i pasliktina ar vesel\u012bbu saist\u012bto dz\u012bves kvalit\u0101ti, mazina remisijas iesp\u0113jam\u012bbu un var sekm\u0113t psori\u0101zes att\u012bst\u012bbu l\u012bdz psori\u0101tiskam artr\u012btam (18\u201320).<br>Psori\u0101ze b\u016btiski pasliktina ar vesel\u012bbu saist\u012bto dz\u012bves kvalit\u0101ti un negat\u012bvi ietekm\u0113 ikdienas aktivit\u0101tes, soci\u0101lo mijiedarb\u012bbu un darbasp\u0113jas. Daudzos p\u0113t\u012bjumos konstat\u0113ts, ka psori\u0101zes pacienti pat vieglas slim\u012bbas gad\u012bjum\u0101 bie\u017ei saskaras ar soci\u0101lu stigmatiz\u0101ciju, kaunu, apmulsumu, fiziskiem ierobe\u017eojumiem un psiholo\u0123isku diskomfortu (17\u201324). Sal\u012bdzinot ar visp\u0101r\u0113jo popul\u0101ciju, psori\u0101ze ir past\u0101v\u012bgi saist\u012bta ar iev\u0113rojamu psiholo\u0123isko slogu (paaugstin\u0101tu depresijas, trauksmes, miega trauc\u0113jumu, pa\u0161n\u0101vniecisku domu, stigmatiz\u0101cijas, zema pa\u0161v\u0113rt\u0113juma un pazemin\u0101tas dz\u012bves kvalit\u0101tes l\u012bmeni), turkl\u0101t slim\u012bbas smaguma pak\u0101pe to pastiprina. Slim\u012bbas hroniskais raksturs, nieze, s\u0101pes un soci\u0101l\u0101 izol\u0101cija v\u0113l vair\u0101k veicina ilgsto\u0161u emocion\u0101lo diskomfortu (20\u201323). Finansi\u0101lais slogs, ko rada izdevumi par vesel\u012bbas apr\u016bpi un darba kav\u0113jumu d\u0113\u013c zaud\u0113tie ien\u0101kumi, v\u0113l vair\u0101k palielina stresu, depresiju un trauksmi (22).<br>NPF veikt\u0101 aptauj\u0101 konstat\u0113ts slimnieku emocion\u0101ls diskomforts: 81% respondentu jut\u0101s apmulsu\u0161i, citiem pamanot vi\u0146u psori\u0101zi, 90% pauda neapmierin\u0101t\u012bbu par neefekt\u012bvu \u0101rst\u0113\u0161anu, 75% jut\u0101s nepievilc\u012bgi, bet 54% cieta no depresijas (2). Cit\u0101 NPF p\u0113t\u012bjum\u0101 tika noskaidrots, ka 26% pacientu ar vid\u0113ji smagu vai smagu psori\u0101zi bija j\u0101maina vai j\u0101p\u0101rtrauc ikdienas aktivit\u0101tes, 40% izv\u0113l\u0113j\u0101s ap\u0123\u0113rbu, kas apsl\u0113pj \u0101das boj\u0101jumus, un 36% sask\u0101r\u0101s ar miega trauc\u0113jumiem (2).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Uzraudz\u012bba un konsult\u0113\u0161ana<\/strong><br>Lai efekt\u012bvi p\u0101rvald\u012btu psori\u0101zi, nepiecie\u0161ama izpratne par t\u0101s rad\u012bto fizisko, psiholo\u0123isko un emocion\u0101lo slogu, k\u0101 ar\u012b par holistiskas, uz pacientu v\u0113rstas pieejas noz\u012bmi, kas mudina pacientus akt\u012bvi iesaist\u012bties \u0101rst\u0113\u0161an\u0101 un apr\u016bp\u0113. Farmaceiti, pateicoties savai kompetencei, ir b\u016btiska starpdisciplin\u0101ras apr\u016bpes komandas da\u013ca, kas optimiz\u0113 \u0101rst\u0113\u0161anu.<br>Pacientu izgl\u012bto\u0161ana par psori\u0101zi, t\u0101s \u0101rst\u0113\u0161anu un terapijas m\u0113r\u0137iem ir neat\u0146emama efekt\u012bvas psori\u0101zes p\u0101rvald\u012bbas da\u013ca, iev\u0113rojami uzlabojot l\u012bdzest\u012bbu un ilgtermi\u0146a kl\u012bniskos rezult\u0101tus (24). Farmaceiti var atbalst\u012bt pacientus ar psori\u0101zi, sniedzot inform\u0101ciju par slim\u012bbu, konsult\u0113jot par pareizu z\u0101\u013cu lieto\u0161anu, pied\u0101v\u0101jot rakstveida un mutv\u0101rdu inform\u0101ciju par v\u0113lamiem rezult\u0101tiem, blakn\u0113m, piesardz\u012bbas pas\u0101kumiem un uzraudz\u012bbu, uzsverot l\u012bdzest\u012bbas noz\u012bmi. Farmaceitiem ir visas iesp\u0113jas identific\u0113t provoc\u0113jo\u0161os faktorus, blaknes un efekt\u012bvas terapijas \u0161\u0137\u0113r\u0161\u013cus. Pier\u0101d\u012bjumi liecina, ka farmaceita iesaist\u012b\u0161an\u0101s uzlabo l\u012bdzest\u012bbu un farmakoterapijas dro\u0161\u012bbu. Ar psori\u0101zi saist\u012btais augstais depresijas, trauksmes un stigmas slogs palielina farmaceita noz\u012bmi gan kl\u012bnisko, gan psiholo\u0123isko vajadz\u012bbu risin\u0101\u0161an\u0101 (24, 25).<br>Papildus atbalsta resursu nodro\u0161in\u0101\u0161anai farmaceiti var pal\u012bdz\u0113t pacientiem ietaup\u012bt izmaksas, padarot \u0101rst\u0113\u0161anas iesp\u0113jas pieejam\u0101kas. Pateicoties bie\u017eai mijiedarb\u012bbai ar pacientiem, farmaceiti var identific\u0113t psori\u0101zes paz\u012bmes un simptomus un mudin\u0101t pacientus mekl\u0113t papildu medic\u012bnisko pal\u012bdz\u012bbu, lai apstiprin\u0101tu diagnozi un sa\u0146emtu \u0101rst\u0113\u0161anu. T\u0101pat farmaceiti var identific\u0113t pacientus, kuri neiev\u0113ro terapijas re\u017e\u012bmu, kuriem pa\u0161reiz\u0113j\u0101 terapija norit problem\u0101tiski vai ar\u012b slim\u012bbas d\u0113\u013c ir par\u0101d\u012bju\u0161ies gar\u012bg\u0101s vesel\u012bbas trauc\u0113jumi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sagatavojusi <strong>Just\u012bne Saara<\/strong><br>p\u0113c Terrie Y. C. Psoriasis and its associated psychological burdens. US Pgarm. 2026; 51 (5): 22\u201326.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>V\u0113res<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Gao Y., Xu T., Wang Y. et al. Pathophysiology and treatment of psoriasis: from clinical practice to basic research. Pharmaceutics. 2025; 17 (1): 56.<\/li>\n\n\n\n<li>Bhutani T., Haberman R., Khattri S. et al. The psoriasis and psoriatic arthritis pocket guide: treatment algorithms and management options. 9th ed. National Psoriasis Foundation. 2026.<\/li>\n\n\n\n<li>National Psoriasis Foundation. Psoriasis statistics. <a href=\"http:\/\/www.psoriasis.org\/psoriasis-statistics\">www.psoriasis.org\/psoriasis-statistics<\/a>.<\/li>\n\n\n\n<li>L\u00f3pez-Estebaranz J. L., S\u00e1nchez-Carazo J. L., Sulleiro S. Effect of a family history of psoriasis and age on comorbidities and quality of life in patients with moderate to severe psoriasis: results from the ARIZONA study. J Dermatol. 2016; 43 (4): 395-401.<\/li>\n\n\n\n<li>Elmets C. A., Leonardi C. L., Davis D. M. R. et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019; 80 (4): 1073-1113.<\/li>\n\n\n\n<li>Gaspari V., Orioni G., Peron I. et al. A case of guttate psoriasis after primary herpetic gingivostomatitis. Int J STD AIDS. 2024; 35 (9): 739-741.<\/li>\n\n\n\n<li>Prajapati V. H., Lynde C. W., Gooderham M. J. et al. Considerations for defining and diagnosing generalized pustular psoriasis. J Eur Acad Dermatol Venereol. 2025; 39 (3): 487-497.<\/li>\n\n\n\n<li>Han G. M., Yang W. S., Yang B. Inhibition of progression of acrodermatitis continua of Hallopeau with baricitinib. JAMA Dermatol. 2021; 157 (4): 466-468.<\/li>\n\n\n\n<li>National Psoriasis Foundation. Erythrodermic psoriasis. <a href=\"http:\/\/www.psoriasis.org\/erythrodermic-psoriasis\/#overview\">www.psoriasis.org\/erythrodermic-psoriasis\/#overview<\/a>.<\/li>\n\n\n\n<li><code>Sbidian E., Chaimani A., Guelimi R. et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2025; (8): CD011535.<\/code><\/li>\n\n\n\n<li><code>Stein Gold L., Soung J., Trenkler N. et al. Impact and insights of psoriasis on quality-of-life and shared decision-making among US adolescents and adults [poster]. Presented at 2025 Fall Clinical Dermatology Conference. Las Vegas, Nevada; 23-26 Oct.<\/code><\/li>\n\n\n\n<li><code>Stein Gold L., Soung J., Trenkler N. et al. Unmet needs and disease burden: perspectives from adults with psoriasis and clinicians treating psoriasis in the US [poster]. Presented at: 2025 Fall Clinical Dermatology Conference. Las Vegas, Nevada; 23-26 Oct.<\/code><\/li>\n\n\n\n<li><code>National Psoriasis Foundation. Treatments for psoriatic disease. www.psoriasis.org\/treatments-for-psoriatic-disease.<\/code><\/li>\n\n\n\n<li><code>Elmets C.A., Korman N.J., Prater E.F. et al. Joint AAD\u2013NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021; 84 (2): 432-470.<\/code><\/li>\n\n\n\n<li><code>National Psoriasis Foundation. Integrative approaches to care. www.psoriasis.org\/integrative-approaches-to-care.<\/code><\/li>\n\n\n\n<li><code>Blauvelt A., Prussick R., Merola J.F. et al. Clarifying psoriasis disease severity: a position statement from the National Psoriasis Foundation Medical Board. J Am Acad Dermatol. 2026; 94 (4): 1348-1349.<\/code><\/li>\n\n\n\n<li><code>McDonough E., Ayearst R., Eder L. et al. Depression and anxiety in psoriatic disease: prevalence and associated factors. J Rheumatol. 2014; 41 (5): 887-896.<\/code><\/li>\n\n\n\n<li><code>Zusman E.Z., Howren A.M., Park J.Y.E. et al. Epidemiology of depression and anxiety in patients with psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2020; 50 (6): 1481-1488.<\/code><\/li>\n\n\n\n<li><code>Michelsen B., Kristianslund E.K., Sexton J. et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017; 76 (11): 1906-1910.<\/code><\/li>\n\n\n\n<li><code>Frede N., Hiestand S., Schauer F. et al. Psoriasis and psoriatic arthritis have a major impact on quality of life and depressive symptoms: a cross-sectional study of 300 patients. Rheumatol Ther. 2023; 10: 1655-1668.<\/code><\/li>\n\n\n\n<li><code>Sahin E., Hawro M., Weller K. et al. Prevalence and factors associated with sleep disturbance in adult patients with psoriasis. J Eur Acad Dermatol Venereol. 2022; 36 (5): 688-697.<\/code><\/li>\n\n\n\n<li><code>Lee K., Kingston P., Huang M. Y. et al. The hidden costs of psoriasis: a population-based study evaluating how psoriasis severity impacts work absenteeism. J Drugs Dermatol. 2024; 23 (8): 640-644.<\/code><\/li>\n\n\n\n<li><code>Luna P. C., Chu C. Y., Fatani M. et al. Psychosocial burden of psoriasis: a systematic literature review of depression among patients with psoriasis. Dermatol Ther (Heidelb). 2023; 13 (12): 3043-3055.<\/code><\/li>\n\n\n\n<li><code>Hiremath A.C., Bhandari R., Wali S. et al. Impact of clinical pharmacist on medication adherence among psoriasis patients: a randomized controlled study. Clin Epidemiol Glob Health. 2021; 10: 100687.<\/code><\/li>\n\n\n\n<li><code>Tucker R., Stewart D. The role of community pharmacists in supporting self-management in patients with psoriasis. Int J Pharm Pract. 2017; 25 (2): 140-146.<\/code><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Psori\u0101ze ir hroniska, recidiv\u0113jo\u0161a slim\u012bba, kuras rad\u012bt\u0101s izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 veicina strauju epidermas atjauno\u0161anos. Psori\u0101zes pato\u0123en\u0113ze ietver \u0123en\u0113tisku predispoz\u012bciju un vides vai dz\u012bvesveida faktoru mijiedarb\u012bbu. Psori\u0101ze ir saist\u012bta ar liel\u0101ku [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[70,76,214],"tags":[],"mic_flag":[],"class_list":["post-23213","post","type-post","status-publish","format-standard","hentry","category-farmacijas-zinas","category-jaunakie-raksti","category-spec-vied"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Psori\u0101ze ir hroniska, recidiv\u0113jo\u0161a slim\u012bba, kuras rad\u012bt\u0101s izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 veicina strauju epidermas atjauno\u0161anos. Psori\u0101zes pato\u0123en\u0113ze ietver \u0123en\u0113tisku predispoz\u012bciju un vides vai dz\u012bvesveida faktoru mijiedarb\u012bbu. Psori\u0101ze ir saist\u012bta ar liel\u0101ku blakusslim\u012bbu skaitu un iev\u0113rojamu psiholo\u0123isko slogu, kas var pasliktin\u0101t dz\u012bves kvalit\u0101ti. Slimniekiem bie\u017ei ir stress, trauksme un depresija. Nieze, s\u0101pes, funkcion\u0101li ierobe\u017eojumi un soci\u0101l\u0101 stigma\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"ugis@mic.lv\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Psori\u0101ze ir hroniska, recidiv\u0113jo\u0161a slim\u012bba, kuras rad\u012bt\u0101s izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 veicina strauju epidermas atjauno\u0161anos. Psori\u0101zes pato\u0123en\u0113ze ietver \u0123en\u0113tisku predispoz\u012bciju un vides vai dz\u012bvesveida faktoru mijiedarb\u012bbu. Psori\u0101ze ir saist\u012bta ar liel\u0101ku blakusslim\u012bbu skaitu un iev\u0113rojamu psiholo\u0123isko slogu, kas var pasliktin\u0101t dz\u012bves kvalit\u0101ti. Slimniekiem bie\u017ei ir stress, trauksme un depresija. Nieze, s\u0101pes, funkcion\u0101li ierobe\u017eojumi un soci\u0101l\u0101 stigma\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-11-20T11:49:22+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-20T11:49:23+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Psori\u0101ze ir hroniska, recidiv\u0113jo\u0161a slim\u012bba, kuras rad\u012bt\u0101s izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 veicina strauju epidermas atjauno\u0161anos. Psori\u0101zes pato\u0123en\u0113ze ietver \u0123en\u0113tisku predispoz\u012bciju un vides vai dz\u012bvesveida faktoru mijiedarb\u012bbu. Psori\u0101ze ir saist\u012bta ar liel\u0101ku blakusslim\u012bbu skaitu un iev\u0113rojamu psiholo\u0123isko slogu, kas var pasliktin\u0101t dz\u012bves kvalit\u0101ti. Slimniekiem bie\u017ei ir stress, trauksme un depresija. Nieze, s\u0101pes, funkcion\u0101li ierobe\u017eojumi un soci\u0101l\u0101 stigma\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"position\":2,\"name\":\"Farm\\u0101cija\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#listItem\",\"name\":\"Psori\\u0101zes farmakoterapija un slim\\u012bbas rad\\u012btais psiholo\\u0123iskais slogs\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#listItem\",\"position\":3,\"name\":\"Psori\\u0101zes farmakoterapija un slim\\u012bbas rad\\u012btais psiholo\\u0123iskais slogs\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#newsarticle\",\"name\":\"Psori\\u0101zes farmakoterapija un slim\\u012bbas rad\\u012btais psiholo\\u0123iskais slogs - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Psori\\u0101zes farmakoterapija un slim\\u012bbas rad\\u012btais psiholo\\u0123iskais slogs\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/noofen.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#articleImage\"},\"datePublished\":\"2026-11-20T13:49:22+02:00\",\"dateModified\":\"2026-11-20T13:49:23+02:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#webpage\"},\"articleSection\":\"Farm\\u0101cija, Jaun\\u0101kie raksti, Speci\\u0101lista viedoklis\",\"dateline\":\"Published on November 20, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/\",\"name\":\"ugis@mic.lv\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4454d24e3c5508a0c61b16269164ff61a96d6a9ea91d5a7a71b99ad72b41784a?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"ugis@mic.lv\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/\",\"name\":\"Psori\\u0101zes farmakoterapija un slim\\u012bbas rad\\u012btais psiholo\\u0123iskais slogs - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Psori\\u0101ze ir hroniska, recidiv\\u0113jo\\u0161a slim\\u012bba, kuras rad\\u012bt\\u0101s izmai\\u0146as im\\u016bnsist\\u0113mas aktivit\\u0101t\\u0113 veicina strauju epidermas atjauno\\u0161anos. Psori\\u0101zes pato\\u0123en\\u0113ze ietver \\u0123en\\u0113tisku predispoz\\u012bciju un vides vai dz\\u012bvesveida faktoru mijiedarb\\u012bbu. Psori\\u0101ze ir saist\\u012bta ar liel\\u0101ku blakusslim\\u012bbu skaitu un iev\\u0113rojamu psiholo\\u0123isko slogu, kas var pasliktin\\u0101t dz\\u012bves kvalit\\u0101ti. Slimniekiem bie\\u017ei ir stress, trauksme un depresija. Nieze, s\\u0101pes, funkcion\\u0101li ierobe\\u017eojumi un soci\\u0101l\\u0101 stigma\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/#author\"},\"datePublished\":\"2026-11-20T13:49:22+02:00\",\"dateModified\":\"2026-11-20T13:49:23+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs - Medikamentu Inform\u0101cijas Centrs","description":"Psori\u0101ze ir hroniska, recidiv\u0113jo\u0161a slim\u012bba, kuras rad\u012bt\u0101s izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 veicina strauju epidermas atjauno\u0161anos. Psori\u0101zes pato\u0123en\u0113ze ietver \u0123en\u0113tisku predispoz\u012bciju un vides vai dz\u012bvesveida faktoru mijiedarb\u012bbu. Psori\u0101ze ir saist\u012bta ar liel\u0101ku blakusslim\u012bbu skaitu un iev\u0113rojamu psiholo\u0123isko slogu, kas var pasliktin\u0101t dz\u012bves kvalit\u0101ti. Slimniekiem bie\u017ei ir stress, trauksme un depresija. Nieze, s\u0101pes, funkcion\u0101li ierobe\u017eojumi un soci\u0101l\u0101 stigma","canonical_url":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","name":"Farm\u0101cija"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","position":2,"name":"Farm\u0101cija","item":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#listItem","name":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#listItem","position":3,"name":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","name":"Farm\u0101cija"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#newsarticle","name":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs - Medikamentu Inform\u0101cijas Centrs","headline":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/09\/noofen.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#articleImage"},"datePublished":"2026-11-20T13:49:22+02:00","dateModified":"2026-11-20T13:49:23+02:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#webpage"},"articleSection":"Farm\u0101cija, Jaun\u0101kie raksti, Speci\u0101lista viedoklis","dateline":"Published on November 20, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/","name":"ugis@mic.lv","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4454d24e3c5508a0c61b16269164ff61a96d6a9ea91d5a7a71b99ad72b41784a?s=96&d=mm&r=g","width":96,"height":96,"caption":"ugis@mic.lv"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/","name":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs - Medikamentu Inform\u0101cijas Centrs","description":"Psori\u0101ze ir hroniska, recidiv\u0113jo\u0161a slim\u012bba, kuras rad\u012bt\u0101s izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 veicina strauju epidermas atjauno\u0161anos. Psori\u0101zes pato\u0123en\u0113ze ietver \u0123en\u0113tisku predispoz\u012bciju un vides vai dz\u012bvesveida faktoru mijiedarb\u012bbu. Psori\u0101ze ir saist\u012bta ar liel\u0101ku blakusslim\u012bbu skaitu un iev\u0113rojamu psiholo\u0123isko slogu, kas var pasliktin\u0101t dz\u012bves kvalit\u0101ti. Slimniekiem bie\u017ei ir stress, trauksme un depresija. Nieze, s\u0101pes, funkcion\u0101li ierobe\u017eojumi un soci\u0101l\u0101 stigma","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/#author"},"datePublished":"2026-11-20T13:49:22+02:00","dateModified":"2026-11-20T13:49:23+02:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs - Medikamentu Inform\u0101cijas Centrs","og:description":"Psori\u0101ze ir hroniska, recidiv\u0113jo\u0161a slim\u012bba, kuras rad\u012bt\u0101s izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 veicina strauju epidermas atjauno\u0161anos. Psori\u0101zes pato\u0123en\u0113ze ietver \u0123en\u0113tisku predispoz\u012bciju un vides vai dz\u012bvesveida faktoru mijiedarb\u012bbu. Psori\u0101ze ir saist\u012bta ar liel\u0101ku blakusslim\u012bbu skaitu un iev\u0113rojamu psiholo\u0123isko slogu, kas var pasliktin\u0101t dz\u012bves kvalit\u0101ti. Slimniekiem bie\u017ei ir stress, trauksme un depresija. Nieze, s\u0101pes, funkcion\u0101li ierobe\u017eojumi un soci\u0101l\u0101 stigma","og:url":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/","article:published_time":"2026-11-20T11:49:22+00:00","article:modified_time":"2026-11-20T11:49:23+00:00","twitter:card":"summary_large_image","twitter:title":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Psori\u0101ze ir hroniska, recidiv\u0113jo\u0161a slim\u012bba, kuras rad\u012bt\u0101s izmai\u0146as im\u016bnsist\u0113mas aktivit\u0101t\u0113 veicina strauju epidermas atjauno\u0161anos. Psori\u0101zes pato\u0123en\u0113ze ietver \u0123en\u0113tisku predispoz\u012bciju un vides vai dz\u012bvesveida faktoru mijiedarb\u012bbu. Psori\u0101ze ir saist\u012bta ar liel\u0101ku blakusslim\u012bbu skaitu un iev\u0113rojamu psiholo\u0123isko slogu, kas var pasliktin\u0101t dz\u012bves kvalit\u0101ti. Slimniekiem bie\u017ei ir stress, trauksme un depresija. Nieze, s\u0101pes, funkcion\u0101li ierobe\u017eojumi un soci\u0101l\u0101 stigma"},"aioseo_meta_data":{"post_id":"23213","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"NewsArticle","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-28 11:57:02","updated":"2026-11-20 14:35:05"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/\" title=\"Farm\u0101cija\">Farm\u0101cija<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tPsori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Farm\u0101cija","link":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/"},{"label":"Psori\u0101zes farmakoterapija un slim\u012bbas rad\u012btais psiholo\u0123iskais slogs","link":"https:\/\/farmacija-mic.lv\/en\/psoriazes-farmakoterapija-un-slimibas-raditais-psihologiskais-slogs\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=23213"}],"version-history":[{"count":2,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23213\/revisions"}],"predecessor-version":[{"id":23517,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23213\/revisions\/23517"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=23213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=23213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=23213"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=23213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}